For citations:

Vizel A.A., Vizel I.Yu. Leflunomide as a potential second-line drug in the treatment of sarcoidosis. Tuberculosis and Lung Diseases. 2019;97(8):52-58. (In Russ.) https://doi.org/10.21292/2075-1230-2019-97-8-52-58